EUVIMEDEUVIMED entdecken
Crossref

Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients

Maxime Perez, Aurélie Maiguy-Foinard, Christine Barthélémy, Bertrand Décaudin, Pascal Odou

Pharmaceutical Technology in Hospital Pharmacy · 2016

DOI: 10.1515/pthp-2016-0004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Technology in Hospital Pharmacy, 2016. Verfasst von Maxime Perez und 4 weiteren Autor:innen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 218 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the fundamental principles guiding the pharmaceutical quality of parenteral products is to prevent injecting contaminants from microbiological, chemical or physical sources. It is just as difficult to ensure the absence of chemical and particulate contaminants in injectable products as it is to weigh up the microbiological risk. The problem of particulate matter is mainly related to the preparing and administrating of injectable drugs rather than through the contamination of marketed products. Particulate contamination also arises

Zitieren

APA

Perez, M., Maiguy-Foinard, A., Barthélémy, C., Décaudin, B., & Odou, P. (2016). Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients. Pharmaceutical Technology in Hospital Pharmacy. https://doi.org/10.1515/pthp-2016-0004

Vancouver

Perez M, Maiguy-Foinard A, Barthélémy C, Décaudin B, Odou P. Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients. Pharmaceutical Technology in Hospital Pharmacy. 2016. doi:10.1515/pthp-2016-0004

BibTeX
@article{Perez2016,
  author = {Perez, Maxime and Maiguy-Foinard, Aurélie and Barthélémy, Christine and Décaudin, Bertrand and Odou, Pascal},
  title = {Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients},
  journal = {Pharmaceutical Technology in Hospital Pharmacy},
  year = {2016},
  doi = {10.1515/pthp-2016-0004}
}
Kostenlos starten →